Mohammed Asmal

Mohammed Asmal

Chief Tech/Sci/R&D Officer at PRIME MEDICINE, INC.

Health Technology
Consumer Services
Finance

Profile

Mohammed Asmal, M.D., Ph.D., is a Venture Partner with OrbiMed.
Prior to joining OrbiMed, Dr. Asmal led clinical research and development in gene therapies for rare diseases at Bluebird Bio.
His prior experience has included leading clinical trials in oncology and infectious diseases at Vertex Pharmaceuticals and attending on the Infectious Disease service at Brigham and Women's Hospital.
He has published scientific articles in peer reviewed journals on HIV pathogenesis and vaccine research.
Dr. Asmal received his A.B.
degree magna cum laude in Biological Sciences and Biomedical Engineering from Harvard University and his joint M.D.-Ph.D.
from Columbia University where he was elected to the Alpha Omega Alpha Medical Honor Society.

Mohammed Asmal active positions

CompaniesPositionStart
PRIME MEDICINE, INC. Chief Tech/Sci/R&D Officer -
All active positions of Mohammed Asmal

Former positions of Mohammed Asmal

CompaniesPositionEnd
BLUEBIRD BIO, INC. Chief Tech/Sci/R&D Officer 2020-03-31
Private Equity Investor -
See the detail of Mohammed Asmal's experience

Training of Mohammed Asmal

Harvard University Undergraduate Degree
The Trustees of Columbia University in The City of New York Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Mohammed Asmal's experience

Connections

41

1st degree connections

5

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies2
BLUEBIRD BIO, INC.

Health Technology

PRIME MEDICINE, INC.

Health Technology

Private companies1

Finance

See company connections
  1. Stock Market
  2. Insiders
  3. Mohammed Asmal
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW